In MSS/pMMR colon cancer, the expression of immune checkpoint genes such as CTLA4, PD-1, and PD-L1 in the APC-mt/MSS group was significantly lower than in the APC-wt/MSS group (Figures 2(c)–2(e)). This evidence concerns the gene CTLA4 and malignant colon neoplasm.